Jeff Cohen
Stock Analyst at Ladenburg Thalmann
(2.83)
# 1,857
Out of 4,761 analysts
10
Total ratings
62.5%
Success rate
25.52%
Average return
Main Sectors:
Stocks Rated by Jeff Cohen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBNX Beta Bionics | Initiates: Buy | $31 | $20.57 | +50.70% | 1 | Feb 20, 2025 | |
| LGCY Legacy Education | Maintains: Buy | $9.1 → $11 | $7.50 | +44.00% | 2 | Feb 14, 2025 | |
| BNGO Bionano Genomics | Downgrades: Neutral | n/a | $5.36 | - | 1 | Nov 15, 2024 | |
| SNOA Sonoma Pharmaceuticals | Initiates: Buy | $65 | $2.40 | +2,613.99% | 1 | Sep 5, 2023 | |
| DKNG DraftKings | Initiates: Overweight | $52 | $45.57 | +14.11% | 1 | Jul 1, 2020 | |
| SE Sea Limited | Initiates: Overweight | $130 | $127.62 | +1.86% | 1 | Jul 1, 2020 | |
| TTWO Take-Two Interactive Software | Maintains: Equal-Weight | $110 → $130 | $211.65 | -38.58% | 3 | May 21, 2020 |
Beta Bionics
Feb 20, 2025
Initiates: Buy
Price Target: $31
Current: $20.57
Upside: +50.70%
Legacy Education
Feb 14, 2025
Maintains: Buy
Price Target: $9.1 → $11
Current: $7.50
Upside: +44.00%
Bionano Genomics
Nov 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.36
Upside: -
Sonoma Pharmaceuticals
Sep 5, 2023
Initiates: Buy
Price Target: $65
Current: $2.40
Upside: +2,613.99%
DraftKings
Jul 1, 2020
Initiates: Overweight
Price Target: $52
Current: $45.57
Upside: +14.11%
Sea Limited
Jul 1, 2020
Initiates: Overweight
Price Target: $130
Current: $127.62
Upside: +1.86%
Take-Two Interactive Software
May 21, 2020
Maintains: Equal-Weight
Price Target: $110 → $130
Current: $211.65
Upside: -38.58%